Skip to main content
SpringerLink
Log in

Schilddrüsenkarzinom

  • Chapter
Book cover Radiologische Diagnostik in der Onkologie

  • 1236 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 3

  • Abdelmoumene N, Schlumberger M, Gardet P et al. (1994) Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69:1141–1144

    PubMed  CAS  Google Scholar 

  • Ain KB, Taylor KD (1994) Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78:1097–1102

    Article  PubMed  CAS  Google Scholar 

  • Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82:1857–1862

    Article  PubMed  CAS  Google Scholar 

  • Akslen L (1993) Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72:2680–2685

    Article  PubMed  CAS  Google Scholar 

  • Akslen L, Myking A (1992) Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress. Virchows Arch A 421:17–23

    Article  CAS  Google Scholar 

  • Akslen L, Myking A, Salvesen H, Varhaug J (1993) Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29A:44–51

    Article  Google Scholar 

  • Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15:1613–1619

    PubMed  CAS  Google Scholar 

  • Astakhova LN, Vorontsova TV, Arozd VM (1994) Thyroid nodule pathology in children of the Republic of Belarus following the Chernobyl accident. In: Robbin J (ed) Treatment of thyroid cancer in childhood. National Institute of Health, Bethesda/MD, pp 5–39

    Google Scholar 

  • Becker N, Wahrendorf J (Hrsg) (1997) Krebsatlas der Bundes-republik Deutschland 1981–1990. Springer, Berlin Heidelberg New York Tokio, p 562

    Google Scholar 

  • Belfiore A, LaRosa GL, LaPorta A et al. (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med 93:363–369

    Article  PubMed  CAS  Google Scholar 

  • Bloom AD, Adler LP, Shuck JM (1993) Determination of malignancy in thyroid nodules with positron emission tomography. Surgery 114:728–735

    PubMed  CAS  Google Scholar 

  • Börner W, Reiners C (Hrsg) (1987) Schilddrüsenmalignome. Diagnostik, Therapie und Nachsorge. Schattauer, Stuttgart, S 176–177

    Google Scholar 

  • Bounacer A, Wicker R, Caillou B (1997) High prevalence of activating ret proto-oncogene rearrangements in thyroid tumors from patients who had received external radiation. Oncogene 15:263–273

    Article  CAS  Google Scholar 

  • Brabant G, Maenhaut C, Köhrle J et al. (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–R12

    Article  PubMed  CAS  Google Scholar 

  • Brasanac D, Jancic-Zgurics M, Jankovic R, Tatic S (1993) Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers. Srp Arh Celok Lek 121:70–73

    PubMed  CAS  Google Scholar 

  • Brincker H, Hansen HS, Andersen AP (1973) Induction of leukemia by treatment of thyroid carcinoma. Br J Cancer 28:232–237

    PubMed  CAS  Google Scholar 

  • Büll U, Schicha A, Biersack HJ, Knapp WH, Reiners C, Schober O (Hrsg) (1996) Nuklearmedizin, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Bur M, Shiraki W, Masood S (1993) Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues. Mod Pathol 6:469–472

    PubMed  CAS  Google Scholar 

  • Burch HB (1995) Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 24:663–710

    PubMed  CAS  Google Scholar 

  • Byar D, Green S, Dor P et al. (1979) A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033–1041

    PubMed  CAS  Google Scholar 

  • Cady B (1997 a) Predictors of thyroid tumor aggressiveness. In: Clark OH, Duh QY (eds) Textbook of endocrine surgery. Saunders, Philadelphia, pp 197–204

    Google Scholar 

  • Cady B (1997b) Basic principles in surgical oncology. Arch Surg 132:338–346

    PubMed  CAS  Google Scholar 

  • Cady B, Rossi C (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947–953

    PubMed  CAS  Google Scholar 

  • Carcangiu M, Zampi G, Pupi A, Castagnoli A, Rosai J (1985) Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–828

    Article  PubMed  CAS  Google Scholar 

  • Chen H, Roberts JR, Ball DW, Eisele DW, Baylin SB, Udelsman R, Bulkley GB (1998) Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg 227:887–895

    Article  PubMed  CAS  Google Scholar 

  • Cooper GM (1992) Oncogenes as markers for early detection of cancer. J Cell Biochem 16(Suppl):131–136

    Article  Google Scholar 

  • Crile GJ (1947) Papillary carcinoma of the thyroid and lateral cervical region: so-called “lateral aberrant thyroid”. Surg Gynecol Obstet 85:757

    Google Scholar 

  • Demeter JG, De Long SA, Lawrence AM et al. (1991) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956–963

    PubMed  CAS  Google Scholar 

  • Deutsche Gesellschaft für Chirurgie (1997) Grundlagen der Chirurgie: Leitlinien zur Therapie maligner Schilddrüsentumoren. Mitteilungen der Deutschen Gesellschaft für Chirurgie 3. Demeter, Balingen

    Google Scholar 

  • Diaz N, Mazoujian G, Wick M (1991) Estrogen receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Arch Pathol Lab Med 115:1203–1207

    PubMed  CAS  Google Scholar 

  • Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H (1997) Fluorine-18 fluoro-deoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:1342–1348

    Article  PubMed  CAS  Google Scholar 

  • DiRenzo MF, Olivero M, Ferro S (1992) Overexpression of the c-MET/HGD receptor gene in human thyroid carcinomas. Oncogene 7:2549–2553

    CAS  Google Scholar 

  • Donghi R, Sozzi G, Pierotti MA (1989) The oncogene associated with human papillary carcinoma (PTC) is assigned to chromosome 10q11–q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene 4:521–523

    PubMed  CAS  Google Scholar 

  • Donis-Keller H, Dou S, Chi D et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851–856

    Article  PubMed  CAS  Google Scholar 

  • Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L (1995) AAssessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 36:21–27

    PubMed  CAS  Google Scholar 

  • Duh QY, Sancho JJ, Greenspan FS et al. (1989) Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 124:1206–1210

    PubMed  CAS  Google Scholar 

  • Dunhill TP (1931) Carcinoma of the thyroid gland. Br J Surg 19:83

    Article  Google Scholar 

  • Egloff B (1987) Histologische Klassifikation der bösartigen Schilddrüsentumoren in Vergangenheit, Gegenwart und Zukunft. In: Börner W, Reiners C (Hrsg) Schilddrüsenmalignome: Diagnostik, Therapie und Nachsorge. Schattauer, Stuttgart, S 3–14

    Google Scholar 

  • Emmertsen K (1985) Medullary thyroid carcinoma and calcitonin. Dan Med Bull 32:1–28

    PubMed  CAS  Google Scholar 

  • Eng C, Smith DP, Mulligan LM et al. (1994) Point mutation within the tyrosine kinase domain of the RET proto-onco-gene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3:237–241 (published erratum p 686)

    Article  PubMed  CAS  Google Scholar 

  • Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP (1993) High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179–184

    Article  PubMed  CAS  Google Scholar 

  • Fagin JA, Tang SH, Zeki K, DiLauro R, Fusco A, Gonsky R (1996) Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53. Cancer Res: 765-771

    Google Scholar 

  • Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W (1996) Fluorine-18-FDG and Iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468–1472

    PubMed  CAS  Google Scholar 

  • Foitzik T (1995) Systematik und Epidemiologie benigner und maligner Schilddrüsenveränderungen. In: Buhr HJ, Runkel N (Hrsg) Operationskurs Schilddrüse. Blackwell, Edinburgh, S 1–14

    Google Scholar 

  • Fonseca E, Sobrinho-Simoes M (1995) Diagnostic problems in differentiated carcinoma of the thyroid. Pathol Res Pract 191:318–331

    PubMed  CAS  Google Scholar 

  • Fonseca E, Soares P, Rossi S, Sobrinho-Simoes M (1997a) Prognosefaktoren bei differenzierten Schilddrüsenkarzino-men. Pathologe 18:275–285

    Article  PubMed  CAS  Google Scholar 

  • Fraker DL (1997) Factors that predispose to thyroid neoplasia. In: Clark OH, Duh QY (eds) Textbook of endocrine surgery. Saunders, Philadelphia, pp 190–196

    Google Scholar 

  • Franissila KO, Harach HR (1985) Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58:715–719

    Article  Google Scholar 

  • Frank-Raue K, Raue F, Buhr HJ et al (1992) Localization of occult persisting medullary thyroid carcinoma before micro-surgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2:113–117

    PubMed  CAS  Google Scholar 

  • Frank-Raue K, Hoppner W, Frilling A (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81:1780–1783

    Article  PubMed  CAS  Google Scholar 

  • Frilling A, Liedke MO (1998) Medüllares Schilddrüsenkarzi-nom: sporadisch/familiär. Wann und warum ein Screening? Internist 39:588–591

    Article  PubMed  CAS  Google Scholar 

  • Frilling A, Dralle H, Eng C, Raue F, Broelsch CE (1995) Pre-symptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery 118:1099–1103

    Article  PubMed  CAS  Google Scholar 

  • Fuchshuber PR, Loree TR, Hicks WL Jr, Cheney RT, Shedd DP (1998) Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol 5:81–86

    Article  PubMed  CAS  Google Scholar 

  • Gardner E, Mulligan LM, Eng C, Healey CS, Kwok JB, Ponder MA, Ponder BA (1994) Haplotype analysis of MEN 2 mutations. Hum Mol Genet 3:1771–1774

    Article  PubMed  CAS  Google Scholar 

  • Gasparoni P, Rubello D, Ferlin G (1997) Potential role of fluo-rin-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma. J Endocrinol Invest 20:527–530

    PubMed  CAS  Google Scholar 

  • Gilliland FD, Hunt WC, Morris DM, Key CR (1996) Prognostic factors for thyroid carcinoma. A population-based study of 15698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79:564–573

    Article  Google Scholar 

  • Girelli ME, Nacamulli D, Pelizzo MR, Vido D de, Mian C, Piccolo M, Busnardo B (1998) Medullary thyroid carcinoma: clinical features and long-term follow up of seventy-eight patients treated between 1969 and 1986. Thyroid 8:517–523

    PubMed  CAS  Google Scholar 

  • Grieco M, Santoro M, Berlingieri M (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human papillary carcinomas. Cell 60: 557–563

    Article  PubMed  CAS  Google Scholar 

  • Gruenwald F, Menzel C, Bender H et al. (1997) Comparison of 18FDG-PET with 131Iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 7:327–335

    Google Scholar 

  • Haberkorn U, Ostertag H (1995) Positronen-Emissions-Tomo-graphie. Dtsch Med Wochenschr 120:1789–1790

    PubMed  CAS  Google Scholar 

  • Haberkorn U, Morr I, Oberdorfer F et al. (1994a) FDG uptake in vitro: methodic aspects and effects of treatment with gemcitabine. J Nucl Med 35:1842–1850

    PubMed  CAS  Google Scholar 

  • Haberkorn U, Ziegler SI, Oberdorfer F et al. (1994b) FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 21: 827–834

    Article  PubMed  CAS  Google Scholar 

  • Hall P, Holm LE, Lundell G et al. (1991) Cancer risks in thyroid cancer patients. Br J Cancer 64:159–163

    PubMed  CAS  Google Scholar 

  • Hamming JF, Goslings BM, Steenis GJ van et al. (1990) The value of fine needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 150:113–116

    Article  PubMed  CAS  Google Scholar 

  • Harness JK (1997) Childhood thyroid carcinoma. In: Clark OH, Duh QY (eds) Textbook of endocrine surgery. Saunders, Philadelphia, pp 75–81

    Google Scholar 

  • Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR (1993) Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. Int J Cancer 55:37–43

    Article  PubMed  CAS  Google Scholar 

  • Hay I (1989) Prognostic factors in thyroid carcinoma. Thyroid Today 12:1–9

    Google Scholar 

  • Hay I (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545–576

    PubMed  CAS  Google Scholar 

  • Hay I, Bergstrahl E, Goellner J (1993) Predicting outcome in papillary thyroid carcinoma. Development of a reliable prognostic system in a cohort of 1779 patients surgically treated of one institution during 1940 through 1989. Surgery 114:1050–1058

    PubMed  CAS  Google Scholar 

  • Hay ID, Grant CS, Bergstrahl EJ, Thompson GB, Heerden JA van, Goellner JR (1998) Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958–966

    PubMed  CAS  Google Scholar 

  • Heyningen V van (1994) One gene — four syndromes. Nature 367:319–320

    Article  PubMed  Google Scholar 

  • Higgins CB, Auffermann W (eds) (1994) Endocrine imaging. Thieme, Stuttgart, pp 55–60

    Google Scholar 

  • Hoang-Vu C, Dralle H, Scheumann G, Maenhaut C, Horn A, Mühlen A, Brabant G (1992) Gene expression of differentiation and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol 100:51–56

    PubMed  CAS  Google Scholar 

  • Hoefnagel CA, Delprat CC, Marcuse HR et al. (1986) Role of thallium-201 total body scintigraphy in follow up of thyroid carcinoma. J Nucl Med 27:1854–1857

    PubMed  CAS  Google Scholar 

  • Hoffmann GL, Thompson NW, Heffron C (1972) The solitary thyroid nodule. A reassessment. Arch Surg 105:379–385

    PubMed  CAS  Google Scholar 

  • Hölting T, Herfarth C (1997) Diagnostik und Therapie von Schilddrüsencarcinomen. Dtsch Med Wochenschr 122: 1077–1080

    PubMed  Google Scholar 

  • Hotz HG, Runkel NS, Frank-Raue K, Raue F, Buhr HJ (1998) Prophylactic thyroidectomy in MEN IIA: Does the calcitonin level correlate with tumor spread? Langenbecks Arch Surg 383:170–173

    PubMed  CAS  Google Scholar 

  • Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 55856 cases of thyroid carcinoma treated in the USA 1985–1995. Cancer 83: 2638–2648

    Article  PubMed  CAS  Google Scholar 

  • Joensuu H, Ahonen A, Klemi PJ (1988) 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy. Eur J Nucl Med 13:502–506

    Article  PubMed  CAS  Google Scholar 

  • Junginger T, Beger HG, Rothmund M, Schober O (1997) Therapie maligner Schilddrüsentumoren. Forum DKG 12:14–21

    Google Scholar 

  • Klugbauer S, Lengfelder E, Demdidchik EP, Rabes HM (1995) High prevalence of RET rearrangements in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11:459–467

    Google Scholar 

  • Klugbauer S, Lengfelder E, Demdidchik EP, Rabes HM (1996) A new form of RET rearrangements in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 13:1099–1102

    PubMed  CAS  Google Scholar 

  • Körle J, Oertel M, Hoang-Yu C, Schmieders F, Brabant G (1993) Type I 5′-deiodinase a marker for differentiated thyroid carcinoma? Exp Clin Endocrinol 101:60–72

    Google Scholar 

  • Lemoine NR, Hughes CM, Gullick WJ, Brown CL, Wynford-Thomas D (1991) Abnormalities of the EGF receptor system in human thyroid neoplasia. Int J Cancer 49:558–561

    Article  PubMed  CAS  Google Scholar 

  • LiVolsi VA (1990) Surgical pathology of the thyroid. Saunders, Philadelphia

    Google Scholar 

  • Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

    Article  PubMed  CAS  Google Scholar 

  • McConahey W, Hay I (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathological findings, therapy, and outcome. Mayo Clin Proc 61:978–996

    PubMed  CAS  Google Scholar 

  • McGrath PC, Sloan DA, Schwartz RW et al. (1994) Diagnosis and management of thyroid malignancies. Curr Opin Oncol 6:60–71

    Article  PubMed  CAS  Google Scholar 

  • Miskin M, Rosen IB, Walfish PG (1975) Ultrasonography of the thyroid gland. Radiol Clin North Am 13:475–492

    Google Scholar 

  • Moretti F, Farsetti A, Soddu S et al. (1997) p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 14:729–740

    Article  PubMed  CAS  Google Scholar 

  • Mulligan LM, Ponder BA (1995) Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80:1989–1995

    Article  PubMed  CAS  Google Scholar 

  • Mulligan LM, Eng C, Healey CS et al. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6:70–74

    Article  PubMed  CAS  Google Scholar 

  • Musholt TJ, Musholt PB, Dedasghti F, Moley JF (1997) Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 122:1049–1061

    Article  PubMed  CAS  Google Scholar 

  • Nikiforov Y, Gnepp DR (1994) Pediatric thyroid cancer after the Chernobyl disaster. Cancer 74:748

    Article  PubMed  CAS  Google Scholar 

  • Noyek AM, Finkelstein D, Witterick IJ, Kirsh JC (1997) Diagnostic imaging of the thyroid gland. In: Falk SA (ed) Thyroid disease. Lippincott-Raven, Philadelphia, pp 135–182

    Google Scholar 

  • Nutz V, Larena-Avellaneda A, Wunsch E et al. (1984) Malignomhäufigkeit und Operationsindikation der Knotenstruma im Endemiegebiet. Dtsch Med Wochenschr 109:1319–1321

    PubMed  CAS  Google Scholar 

  • Oberwittler H, Nawroth PP, Ziegler R, Seibel MJ (1998) Klinik des Schilddrüsenkarzinoms. Tumordiagn Ther 19:52–55

    Google Scholar 

  • Ohta K, Endo T, Onaya T (1991) The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neo-plastic human thyroid tissues. Biochem Biophys Res Commun 174:1148–1153

    Article  PubMed  CAS  Google Scholar 

  • Pelizzo MR, Busnardo B, Bernante P, Girelli ME, Nacamulli D, Toniato A, Piotto A (1993) Medullary thyroid carcinoma: prognostic factors. Minerva Chir 48:1289–1291

    PubMed  CAS  Google Scholar 

  • Pfannenstiel P, Hotze LA, Sailer B (Hrsg) (1997) Schilddrüsen-krankheiten: Diagnose und Therapie, 3. Aufl. Henning, Berlin

    Google Scholar 

  • Pfeilschifter J (1998) Medikamentöse Therapie und Nachsorge von Schilddrüsenkarzinomen. Tumordiagn Ther 19:79–85

    Google Scholar 

  • Powell ME, Moskowic EC, Harmer CL (1994) Surveillance after treatment for well differentiated thyroid cancer: audit for chest radiography. Clin Oncol (R Coll Radiol) 6:151–153

    Article  CAS  Google Scholar 

  • Quadbeck B, Mann K (1998) Die maligne Struma: Diagnostik des Schilddrüsenkarzinoms. Tumordiagn Ther 19:56–59

    Google Scholar 

  • Raue F, Kotzerke J, Reinwein D et al. (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Invest 71:7–12

    Article  CAS  Google Scholar 

  • Reiners C (1998) Radiojodtherapie des Schilddrüsenkarzinoms. Tumordiagn Ther 19:70–74

    Google Scholar 

  • Reiners C, Börner W (1980) Zur Diagnose und Verlaufskontrolle des Schilddrüsenmalignoms. Nuklearmedizin 3:193

    Google Scholar 

  • Reinwein D, Benker G (1988) Checkliste Endokrinologie und Stoffwechsel. Thieme, Stuttgart

    Google Scholar 

  • Reinwein D, Benker G (1996) Schilddrüsenmalignom. In: Sturm A, Largiader F, Wicki O (Hrsg) Checkliste Endokrinologie und Stoffwechsel. Thieme, Stuttgart, S 211

    Google Scholar 

  • Reinwein D, Benker G, Windeck R et al. (1989) Erstsymptome bei Schilddrüsenmalignomen: Einfluß von Alter und Geschlecht in einem Jodmangelgebiet. Dtsch Med Wochenschr 114:775–782

    PubMed  CAS  Google Scholar 

  • Reubi JC, Schaer JC, Waser B, Mengod G (1994) Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455–3459

    PubMed  CAS  Google Scholar 

  • Riddell DA, Lampe HB, Cramer H, Troster M (1993) Medullary thyroid carcinoma: prognostic factors. J Otolaryngol 22:180–183

    PubMed  CAS  Google Scholar 

  • Roedler HD (1987) Induktion von Schilddrüsenkrebs durch ionisierende Strahlung. In: Börner W, Reiners C (Hrsg) Schilddrüsenmalignome. Diagnostik, Therapie und Nachsorge. Schattauer, Stuttgart, S 19–34

    Google Scholar 

  • Roeher HD, Simon D, Goretzki PE, Hoppner W, Lederbogen S, Seppel T (1995) Die prophylaktische Radikaloperation des C-Zell-Carcinoms beim MEN-II-Syndrom auf der Grundlage des genetischen Screening. Chirurg 66:1196–1202

    Google Scholar 

  • Ron E, Modan B, Preston D et al. (1989) Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 120:516

    Article  PubMed  CAS  Google Scholar 

  • Rosai J (1995) Thyroid gland. In: Ackerman’s surgical pathology, 8th edn. Mosby, St. Louis/MO, pp 493–567

    Google Scholar 

  • Rosai J, Carangiu M, De Lellis R (1992) Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series. Armed Forces Institute of Pathology, Washington/DC

    Google Scholar 

  • Rougier P, Parmentier C, LaPlanche A et al. (1983) Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys 9:161–169

    PubMed  CAS  Google Scholar 

  • Sanders LE, Silverman M (1998) Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. Surgery 124:967–974

    PubMed  CAS  Google Scholar 

  • Sato N, Oyamatsu M, Koyama Y, Emura I, Tamiya Y, Hatakeyama K (1998) Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151–155

    Article  PubMed  CAS  Google Scholar 

  • Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C (1988) Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 29:1790–1794

    PubMed  CAS  Google Scholar 

  • Schmutzler C, Brtko J, Winzer R et al. (1998) Functional retinoid and thyroid hormone receptors in human thyroid carcinoma cell lines and tissues. Int J Cancer 76:368–376

    Article  PubMed  CAS  Google Scholar 

  • Schrager VL (1966) Lateral aberrant thyroids. Am J Surg 163:165

    Google Scholar 

  • Schreck R, Schmieders F, Schmutzler C, Körle J (1994) Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular carcinoma cell lines. J Clin Endocrinol Metab 79:791–798

    Article  PubMed  CAS  Google Scholar 

  • Schuffenecker I, Billaud M, Calender A et al. (1994) RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3:1939–1943

    Article  PubMed  CAS  Google Scholar 

  • Shore RE, Woodard E, Hildreth N et al. (1985) Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74:1177

    PubMed  CAS  Google Scholar 

  • Simon D, Goretzki P, Röher H (1993) The significance of c-neu and p53 in endocrine tumors. Langenbecks Arch Surg 2:69–75

    Google Scholar 

  • Simon D, Köhrle J, Schmutzler C et al. (1996) Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results. Exp Clin Endocrinol Diabetes 104(Suppl):13–15

    Article  PubMed  CAS  Google Scholar 

  • Smit JW, Pluijm G, Vloedgraven HJ, Löwik CW, Goslings BM (1998) Role of integrin in the attachment of metastatic follicular thyroid carcinoma cell lines to bone. Thyroid 8: 29–36

    Article  PubMed  CAS  Google Scholar 

  • Smith DP, Eng C, Ponder BA (1994) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease. J Cell Sci (Suppl) 18:43–49

    CAS  Google Scholar 

  • Sophocleus S (1994) Das differenzierte low-risk Schilddrüsenkarzinom. Diagnose, Therapie, Nachsorge und Prognose. Med Dissertation, Medizinische Hochschule Hannover

    Google Scholar 

  • Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, So-bin LH, Wagner G (eds) (1992) Manual for staging of cancer: American Joint Committee on Cancer. Lippincott, Philadelphia

    Google Scholar 

  • Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G (Hrsg) (1993) TNM-Atlas. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 3. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Sugawara I, Arai T, Yamashita T, Yoshida A, Masunaga A, Itoyama S (1994) Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid. Cancer Lett 82:185–188

    Article  PubMed  CAS  Google Scholar 

  • Tenenbaum F, Lumbroso J, Schlumberger M, Caillou B, Fragu P, Parmentier C (1995) Radiolabeled somatostatin analog scintigraphy in differentiated thyroid cancer. J Nucl Med 36:807–810

    PubMed  CAS  Google Scholar 

  • Tisell LE, Dilley WG, Wells SA Jr (1996) Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 119:34–39

    Article  PubMed  CAS  Google Scholar 

  • Trohler U (1984) Der Nobelpreistrager Theodor Kocher (1841–1917). Auf dem Weg zur physiologischen Chirurgie. Birkhäuser, Basel

    Google Scholar 

  • Tsang RW, Brierly JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82:375–388

    Article  PubMed  CAS  Google Scholar 

  • Uchida Y, Matsuno N, Minoshima S, Imazeki K, Uno K, Kitahara H (1995) Diagnostic value of 18F-FDG PET in primary and metastatic thyroid cancer. J Nucl Med 36:196P

    Google Scholar 

  • Uematsu H, Sadato N, Ohtsubo T et al. (1998) Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453–459

    PubMed  CAS  Google Scholar 

  • Wegelin C (1926) Schilddriise. In: Henke F, Lubarsch O (Hrsg) Handbuch der speziellen pathologischen Anatomie und Histologie. Springer, Berlin

    Google Scholar 

  • Wiedemann W (1993) Sonographie und Szintigraphie der Schilddrüse, 2. Aufl. Thieme, S 134–139

    Google Scholar 

  • Wieler HJ (1999) PET in der klinischen Onkologie. Steinkopff, Darmstadt

    Google Scholar 

  • Wilson NW, Pambakian H, Richardson TC, Stokoe MR, Makin CA (1986) Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Histopathology 10:815–829

    Article  PubMed  CAS  Google Scholar 

  • Wittekind C, Klimpfinger M, Sobin LH (Hrsg) (2005) TNM-Atlas. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Wright PA, Lemoine NR, Goretzki PE (1991) Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumors. Oncogene 6:693–697

    Google Scholar 

  • Wynford-Thomas D (1993) Molecular basis of epithelial tumorigenesis: the thyroid model. Crit Rev Oncog 4:1–23

    PubMed  CAS  Google Scholar 

  • Zornig C, Heer K de, Koenecke S, Engel U, Bay V (1989) Darstellung des N. recurrens bei Schilddriisenoperationen — Standortbestimmung. Chirurg 60:44–48

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Nuklearmedizin Radiologische Klinik, Ruprecht-Karls-Universität, Im Neuenheimer Feld 400, 69120, Heidelberg

    S. Hoffher (Dr. med.) & U. Haberkorn (Prof. Dr. med.)

  2. Chirurgische Klinik, Universitätsklinikum Mannheim Fakultät für Klinische Medizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim

    F. Willeke (PD Dr. med.)

Authors
  1. S. Hoffher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Willeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Haberkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentralinstitut für Diagnostische und Interventionelle Radiologie, Klinikum der Stadt Ludwigshafen, Bremserstraße 79, 67063, Ludwigshafen

    Günter Layer

  2. Forschungsschwerpunkt Radiologische Diagnostik und Therapie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg

    Gerhard van Kaick

  3. Abteilung Radiologie (E010), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg

    Stefan Delorme

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoffher, S., Willeke, F., Haberkorn, U. (2006). Schilddrüsenkarzinom. In: Layer, G., van Kaick, G., Delorme, S. (eds) Radiologische Diagnostik in der Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33565-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33565-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66991-3

  • Online ISBN: 978-3-540-33565-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation